BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 20, Issue 26
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (10151)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.
Item 
Count 
PDF652
WORD368
HTML6761
Figures (1-1)233
Tables (1-1)236
 Sum=8250
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse938
Download963
 Sum=1901
Jul 14, 2014 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Liu H, Lu HY. Nonalcoholic fatty liver disease and cardiovascular disease. World J Gastroenterol 2014; 20(26): 8407-8415 [PMID: 25024598 DOI: 10.3748/wjg.v20.i26.8407]
URL: https://www.wjgnet.com/1007-9327/full/v20/i26/8407.htm
Number Citing Articles
1
Rajkumar Chinnadurai, James Ritchie, Darren Green, Philip A Kalra. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease. Nephrology Dialysis Transplantation 2019; 34(3): 449 doi: 10.1093/ndt/gfx381
2
Rongjiong Zheng, Zhennan Du, Mingming Wang, Yushan Mao, Wenjie Mao. A longitudinal epidemiological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver disease. Lipids in Health and Disease 2018; 17(1) doi: 10.1186/s12944-018-0913-3
3
Qun Liu, Shou-Sheng Liu, Zhen-Zhen Zhao, Ben-Tian Zhao, Shui-Xian Du, Wen-Wen Jin, Yong-Ning Xin. TRIB1 rs17321515 gene polymorphism increases the risk of coronary heart disease in general population and non-alcoholic fatty liver disease patients in Chinese Han population. Lipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-1108-2
4
Yu Mi Kang, Chang Hee Jung, Yun Kyung Cho, Seung Eun Lee, Min Jung Lee, Jenie Yoonoo Hwang, Eun Hee Kim, Joong-Yeol Park, Woo Je Lee, Hong-Kyu Kim, Petter Bjornstad. Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population. PLOS ONE 2017; 12(4): e0175762 doi: 10.1371/journal.pone.0175762
5
Toufik Mahfood Haddad, Shadi Hamdeh, Arun Kanmanthareddy, Venkata M. Alla. Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2017; 11: S209 doi: 10.1016/j.dsx.2016.12.033
6
Aki Juhani Käräjämäki, Risto Bloigu, Heikki Kauma, Y. Antero Kesäniemi, Olli-Pekka Koivurova, Juha Perkiömäki, Heikki Huikuri, Olavi Ukkola. Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes. Metabolism 2017; 66: 55 doi: 10.1016/j.metabol.2016.06.009
7
Christopher L. Wray. Advances in the Anesthetic Management of Solid Organ Transplantation. Advances in Anesthesia 2017; 35(1): 95 doi: 10.1016/j.aan.2017.07.005
8
Shima Dowla Anwar, Christy Foster, Ambika Ashraf. Lipid Disorders and Metabolic-Associated Fatty Liver Disease. Endocrinology and Metabolism Clinics of North America 2023; 52(3): 445 doi: 10.1016/j.ecl.2023.01.003
9
Sara Shojaei-Zarghani, Nastaran Najafi, Mohammad Reza Fattahi, Ali Reza Safarpour. Influence of Garlic on the Glycemic Control and Lipid Profile in Animals with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Planta Medica 2023; 89(12): 1125 doi: 10.1055/a-2112-6204
10
Gaofeng Yuan, Mengmeng Xu, Meijuan Tan, Jian Dong, Xiaoe Chen. Supplementation with Docosahexaenoic Acid and Vitamin E Improves Hepatic Triglyceride Accumulation Induced by High‐Fat Diet in Mice. European Journal of Lipid Science and Technology 2021; 123(1) doi: 10.1002/ejlt.202000224
11
Benedicto Crespo-Facorro, Jose Maria Pelayo-Teran, Jacqueline Mayoral-van Son. Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive Review. Neurology and Therapy 2016; 5(2): 105 doi: 10.1007/s40120-016-0050-8
12
Hui-Li Tan, Kok-Gan Chan, Priyia Pusparajah, Acharaporn Duangjai, Surasak Saokaew, Tahir Mehmood Khan, Learn-Han Lee, Bey-Hing Goh. Rhizoma Coptidis: A Potential Cardiovascular Protective Agent. Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00362
13
Nikolaos Ktenopoulos, Marios Sagris, Maria Gerogianni, Konstantinos Pamporis, Anastasios Apostolos, Konstantinos Balampanis, Konstantinos Tsioufis, Konstantinos Toutouzas, Dimitris Tousoulis. Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: A Bidirectional Association Based on Endothelial Dysfunction. International Journal of Molecular Sciences 2024; 25(19): 10595 doi: 10.3390/ijms251910595
14
Manya Prasad, Sunanda Gupta, Shiv K. Sarin. The Independent Association of Non-alcoholic Fatty Liver Disease With Incident Cardiovascular Disease: A GRADE Evaluation of the Evidence Through a Systematic Review and Meta-analysis. Journal of Clinical and Experimental Hepatology 2024; 14(1): 101277 doi: 10.1016/j.jceh.2023.08.013
15
Nasrin Sharifi, Reza Amani, Eskandar Hajiani, Bahman Cheraghian. Women may respond different from men to vitamin D supplementation regarding cardiometabolic biomarkers. Experimental Biology and Medicine 2016; 241(8): 830 doi: 10.1177/1535370216629009
16
Katherine Blackmore, Claire J. Houchen, Hayk Simonyan, Hovhannes Arestakesyan, Alyssa K. Stark, Samantha A. Dow, Han Rae Kim, Jin Kwon Jeong, Anastas Popratiloff, Colin N. Young. A forebrain-hypothalamic ER stress driven circuit mediates hepatic steatosis during obesity. Molecular Metabolism 2024; 79: 101858 doi: 10.1016/j.molmet.2023.101858
17
Xiao-Yan Wang, Xue-Lan Song, Yi Zhang, Gan Luo, Hai-Chuan Tai, Zhao-Heng Lin, Pei-Li Zhu, Nan Sun, Zhu-Sheng Chu, Zhi-Ling Yu, Si-Yuan Pan, Jin-Fa Tang, Kam-Ming Ko, Jenny Wilkinson. Evaluation of Beneficial and Adverse Effects of a Diet Supplemented with Schisandrae Fructus Seed Ethanol Extract on Lipid and Glucose Metabolism in Normal and Hypercholesterolemic/Hyperglycemic Mice. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/8858962
18
Ivana Mikolasevic, Sandra Milic, Tamara Turk Wensveen, Ivana Grgic, Ivan Jakopcic, Davor Stimac, Felix Wensveen, Lidija Orlic. Nonalcoholic fatty liver disease - A multisystem disease?. World Journal of Gastroenterology 2016; 22(43): 9488-9505 doi: 10.3748/wjg.v22.i43.9488
19
Sheila Gato, Vanessa García-Fernández, Antonio Gil-Gómez, Ángela Rojas, Rocío Montero-Vallejo, Rocío Muñoz-Hernández, Manuel Romero-Gómez. Navigating the Link Between Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis and Cardiometabolic Syndrome. European Cardiology Review 2024; 19 doi: 10.15420/ecr.2023.26
20
Veeravich Jaruvongvanich, Kamonkiat Wirunsawanya, Anawin Sanguankeo, Sikarin Upala. Nonalcoholic fatty liver disease is associated with coronary artery calcification: A systematic review and meta-analysis. Digestive and Liver Disease 2016; 48(12): 1410 doi: 10.1016/j.dld.2016.09.002
21
Lu Liu, Yong Yu, Meng Zhao, Dongmei Zheng, Xu Zhang, Qingbo Guan, Chao Xu, Ling Gao, Jiajun Zhao, Haiqing Zhang. Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients. International Journal of Endocrinology 2017; 2017: 1 doi: 10.1155/2017/5753039
22
Dawn M. Torres, Stephen A. Harrison. Alcoholic and Non-Alcoholic Fatty Liver Disease. 2016; : 183 doi: 10.1007/978-3-319-20538-0_9
23
Vasilios G Athyros, Konstantinos Tziomalos, Niki Katsiki, Michael Doumas, Asterios Karagiannis, Dimitri P Mikhailidis. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update. World Journal of Gastroenterology 2015; 21(22): 6820-6834 doi: 10.3748/wjg.v21.i22.6820
24
Nicholas W.S. Chew, Bryan Chong, Cheng Han Ng, Gwyneth Kong, Yip Han Chin, Wang Xiao, Mick Lee, Yock Young Dan, Mark D. Muthiah, Roger Foo. The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.971484
25
Sarita Singhal, Susan S. Baker, Robert D. Baker, Lixin Zhu. The Liver. 2018; : 15 doi: 10.1016/B978-0-12-803951-9.00002-1
26
Faezeh Yarhosseini, Abbas Ali Sangouni, Zohreh Sadat Sangsefidi, Mahdieh Hosseinzadeh, Mohsen Akhondi-Meybodi, Alimohammad Ranjbar, Hossein Fallahzadeh, Hassan Mozaffari-Khosravi. Effect of Cornus mas L. fruit extract on blood pressure, anthropometric and body composition indices in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled trial. Clinical Nutrition ESPEN 2023; 56: 18 doi: 10.1016/j.clnesp.2023.04.018
27
Vikash Jaiswal, Song Peng Ang, Helen Huang, Navroop Kaur Momi, Maha Hameed, Sidra Naz, Nitya Batra, Angela Ishak, Neel Doshi, Asmita Gera, Medha Sharath, Madeeha Subhan Waleed, Nishchita Raj, Victor Hugo Aguilera Alvarez. Association between nonalcoholic fatty liver disease and atrial fibrillation and other clinical outcomes: a meta-analysis. Journal of Investigative Medicine 2023; 71(6): 591 doi: 10.1177/10815589231164777
28
Radojica V. Stolic, Goran Z. Trajkovic, Mirjana M. Kostic, Sasa R. Sovtic, Andrijana M. Odalovic, Biljana D. Krdzic, Maja V. Sipic, Snezana Lazic, Zorica N. Sojevic-Timotijevic. Correlation between nonalcoholic fatty liver and cardiovascular disease in elderly hemodialysis patients. International Urology and Nephrology 2016; 48(6): 883 doi: 10.1007/s11255-016-1237-8
29
Narjes Khavasi, Mohammadhossein Somi, Ebrahim Khadem, Mohammad Hossein Ayati, Mohamadali Torbati, Seyyed Muhammad Bagher Fazljou. Daily Consumption of the Capparis spinosa Reduces Some Atherogenic Indices in Patients with Non-alcoholic Fatty Liver Disease: A Randomized, Double-blind, Clinical Trial. Iranian Red Crescent Medical Journal 2018; (In Press) doi: 10.5812/ircmj.63446
30
Dan-Qin Sun, Sheng-Jie Wu, Wen-Yue Liu, Li-Ren Wang, Yi-Ran Chen, Dong-Chu Zhang, Martin Braddock, Ke-Qing Shi, Dan Song, Ming-Hua Zheng. Association of low-density lipoprotein cholesterol within the normal range and NAFLD in the non-obese Chinese population: a cross-sectional and longitudinal study. BMJ Open 2016; 6(12): e013781 doi: 10.1136/bmjopen-2016-013781
31
Naoko Nakanishi, Yoshitaka Hashimoto, Takuro Okamura, Akihiro Ohbora, Takao Kojima, Masahide Hamaguchi, Michiaki Fukui. A weight regain of 1.5 kg or more and lack of exercise are associated with nonalcoholic fatty liver disease recurrence in men. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-99036-y
32
Alen Lovric, Marit Granér, Elias Bjornson, Muhammad Arif, Rui Benfeitas, Kristofer Nyman, Marcus Ståhlman, Markku O. Pentikäinen, Jesper Lundbom, Antti Hakkarainen, Reijo Sirén, Markku S. Nieminen, Nina Lundbom, Kirsi Lauerma, Marja-Riitta Taskinen, Adil Mardinoglu, Jan Boren. Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolome. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-31865-w
33
Simone Schimmenti, Francesca Maria Camilla Maselli, Sarah Tosato. Prevention in Mental Health. 2022; : 225 doi: 10.1007/978-3-030-97906-5_13
34
Mark CC Cheah, Arthur J McCullough, George Boon-Bee Goh. Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease. Journal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2017.00009
35
Alessandro Ciavarella, Davide Gnocchi, Carlo Custodero, Gennaro Mariano Lenato, Giorgio Fiore, Carlo Sabbà, Antonio Mazzocca. Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease. Thrombosis Research 2021; 198: 139 doi: 10.1016/j.thromres.2020.12.002
36
Danting Li, Shengli Wu, Meiyu Zhang, Chengyao Xie, Huiwen Tan, Nong Li. Correlation between triglyceride-glucose index and related parameters and nonalcoholic fatty liver disease in northwest China. International Journal of Diabetes in Developing Countries 2024; 44(3): 496 doi: 10.1007/s13410-023-01255-8
37
Gerardo Rodriguez-Araujo, Andrew J. Krentz. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. 2019; : 275 doi: 10.1007/978-3-030-11748-1_11
38
Carla Sá, Ana Rita Oliveira, Cátia Machado, Marisa Azevedo, Cristina Pereira-Wilson. Effects on Liver Lipid Metabolism of the Naturally Occurring Dietary Flavone Luteolin-7-glucoside. Evidence-Based Complementary and Alternative Medicine 2015; 2015: 1 doi: 10.1155/2015/647832
39
Abdulrahman Ismaiel, Dan L. Dumitraşcu. Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis—Literature Review. Frontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00202
40
Stefania Kiapidou, Christina Liava, Maria Kalogirou, Evangelos Akriviadis, Emmanouil Sinakos. Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?. Annals of Hepatology 2020; 19(2): 134 doi: 10.1016/j.aohep.2019.07.013
41
Derek Ugwendum, Mouhanad Mohamed, Yazan A Al-Ajlouni, Nso Nso, Basile Njei. Association of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) With an Increased Risk of Congestive Heart Failure in Hospitalized Patients With Cirrhosis: A Propensity Score-Matched Analysis. Cureus 2024;  doi: 10.7759/cureus.62441
42
Yaohui Wang, Yuhua Zeng, Changwei Lin, Zhiheng Chen. Hypertension and non‐alcoholic fatty liver disease proven by transient elastography. Hepatology Research 2016; 46(13): 1304 doi: 10.1111/hepr.12688
43
Elisabete Martins, Ana Oliveira. NAFLD and cardiovascular disease. Porto Biomedical Journal 2018; 3(2): e2 doi: 10.1016/j.pbj.0000000000000002
44
Masayoshi Takeuchi, Jun-ichi Takino, Akiko Sakasai-Sakai, Takanobu Takata, Tadashi Ueda, Mikihiro Tsutsumi, Hideyuki Hyogo, Sho-ichi Yamagishi. Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies. World Journal of Hepatology 2014; 6(12): 880-893 doi: 10.4254/wjh.v6.i12.880
45
Tessa Brand, Inge Christina Lamberta van den Munckhof, Marinette van der Graaf, Kiki Schraa, Helena Maria Dekker, Leonardus Antonius Bernardus Joosten, Mihai Gheorghe Netea, Niels Peter Riksen, Jacqueline de Graaf, Joseph Henricus Wilhelmus Rutten. Superficial vs Deep Subcutaneous Adipose Tissue: Sex-Specific Associations With Hepatic Steatosis and Metabolic Traits. The Journal of Clinical Endocrinology & Metabolism 2021; 106(10): e3881 doi: 10.1210/clinem/dgab426
46
Nilesh Toke, Ajit Rathod, Pooja Phalak, Vikas Patel. Endothelial dysfunction and cardiovascular risk in non-alcoholic fatty liver disease – a systematic review and meta-analysis. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00348-1
47
Fatemeh Sadeghi, Sasan Amanat, Mohammad Bakhtiari, Hadis Asadimehr, Mohammad Ali Okhovat, Masood Hosseinzadeh, Seyed Mohammad Mazloomi, Maryam Gholamalizadeh, Saeid Doaei. The effects of high fructose fruits and honey on the serum level of metabolic factors and nonalcoholic fatty liver disease. Journal of Diabetes & Metabolic Disorders 2021; 20(2): 1647 doi: 10.1007/s40200-021-00916-x
48
Karthik Chandrasekharan, William Alazawi. Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy?. Frontiers in Pharmacology 2020; 10 doi: 10.3389/fphar.2019.01413
49
Georgiana-Diana Cazac, Cristina-Mihaela Lăcătușu, Cătălina Mihai, Elena-Daniela Grigorescu, Alina Onofriescu, Bogdan-Mircea Mihai. New Insights into Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: The Liver-Heart Axis. Life 2022; 12(8): 1189 doi: 10.3390/life12081189
50
O. Ya. Babak, A. D. Bashkirova . Parameters of Carbohydrate Metabolism and Expression of Liver Steatosis in Patients with Nonalcoholic Fatty Liver Disease and Hypertensive Depending on Lipid Parameters. Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 2019; 4(4): 64 doi: 10.26693/jmbs04.04.064
51
Partha Sarathi Singha, Suvendu Ghosh, Debosree Ghosh. Levothyroxine and Non-alcoholic Fatty Liver Disease: A Mini Review. Mini-Reviews in Medicinal Chemistry 2024; 24(2): 128 doi: 10.2174/1389557523666230314113543
52
Shenyi Yin, Yu Fan, Hanshuo Zhang, Zhihua Zhao, Yang Hao, Juan Li, Changhong Sun, Junyu Yang, Zhenjun Yang, Xiao Yang, Jian Lu, Jianzhong Jeff Xi. Differential TGFβ pathway targeting by miR-122 in humans and mice affects liver cancer metastasis. Nature Communications 2016; 7(1) doi: 10.1038/ncomms11012
53
Hamza El Hadi, Angelo Di Vincenzo, Roberto Vettor, Marco Rossato. Relationship between Heart Disease and Liver Disease: A Two-Way Street. Cells 2020; 9(3): 567 doi: 10.3390/cells9030567
54
Ruby Kumari, Prof. Santosh Kumar, Debarshi Jana. DYSLIPIDEMIA IN NON ALCOHOLIC FATTY LIVER DISEASE. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH 2021; : 24 doi: 10.36106/ijsr/9739450
55
Asako Nogami, Masato Yoneda, Takashi Kobayashi, Takaomi Kessoku, Yasushi Honda, Yuji Ogawa, Kaori Suzuki, Wataru Tomeno, Kento Imajo, Hiroyuki Kirikoshi, Tomoko Koide, Hirotoshi Fujikawa, Satoru Saito, Atsushi Nakajima. Assessment of 10‐year changes in liver stiffness using vibration‐controlled transient elastography in non‐alcoholic fatty liver disease. Hepatology Research 2019; 49(8): 872 doi: 10.1111/hepr.13349
56
Jihyun Kim, Da Young Lee, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee, Susanne Kaser. Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation. PLOS ONE 2017; 12(7): e0180118 doi: 10.1371/journal.pone.0180118
57
M. E. Statsenko, A. M. Streltsova. The role of non-alcoholic fatty liver disease in the development of vascular rigidity and cardiovascular risk in patients with arterial hypertension. Experimental and Clinical Gastroenterology 2021; (10): 14 doi: 10.31146/1682-8658-ecg-194-10-14-21
58
Seyedeh Neda Mousavi, Amirhosein Faghihi, Majid Motaghinejad, Maryam Shiasi, Fatemeh Imanparast, Hamid Lorvand Amiri, Farzad Shidfar. Zinc and Selenium Co-supplementation Reduces Some Lipid Peroxidation and Angiogenesis Markers in a Rat Model of NAFLD-Fed High Fat Diet. Biological Trace Element Research 2018; 181(2): 288 doi: 10.1007/s12011-017-1059-2
59
Alessandra Gentili, Giulia Daviddi, Stefano De Vuono, Maria Anastasia Ricci, Francesco Di Filippo, Abdalkader Alaeddin, Massimo R. Mannarino, Marcello Boni, Gaetano Vaudo, Graziana Lupattelli. Non-alcoholic fatty liver disease fibrosis score and preclinical vascular damage in morbidly obese patients. Digestive and Liver Disease 2016; 48(8): 904 doi: 10.1016/j.dld.2016.04.004
60
Mostafa Fazeli, Mohammad Mohammad-Zadeh, Zahra Meshkat, Hamideh Ghazizadeh, Elham Barati, Gordon A Ferns, Majid Ghayour-Mobarhan. Metabolic Syndrome in Children and Adolescents: Looking to New Markers. Current Treatment Options in Pediatrics 2021; 7(3): 152 doi: 10.1007/s40746-021-00226-7
61
Jung Eun Lee, Yong Jae Lee, Soo Yoon Chung, Hee Woo Cho, Byoung Jin Park, Dong Hyuk Jung, Kottarappat N Dileepan. Severity of nonalcoholic fatty liver disease is associated with subclinical cerebro-cardiovascular atherosclerosis risk in Korean men. PLOS ONE 2018; 13(3): e0193191 doi: 10.1371/journal.pone.0193191
62
Mary Cushman, Peter W. Callas, Kristine S. Alexander, Virginia Wadley, Neil A. Zakai, Steven D. Lidofsky, Frederick W. Unverzagt, Suzanne E. Judd, Nicholette D. Palmer. Nonalcoholic fatty liver disease and cognitive impairment: A prospective cohort study. PLOS ONE 2023; 18(4): e0282633 doi: 10.1371/journal.pone.0282633
63
永昊 文. Bayesian Single-Arm Meta-Analysis of Nonalcoholic Fatty Liver Disease in China in Recent 10 Years. Advances in Clinical Medicine 2023; 13(12): 19692 doi: 10.12677/ACM.2023.13122772
64
Sevket Balta. Atherosclerosis and Non-Alcoholic Fatty Liver Disease. Angiology 2022; 73(8): 701 doi: 10.1177/00033197221091317
65
Aki J. Käräjämäki, Olli-Pekka Pätsi, Markku Savolainen, Y. Antero Kesäniemi, Heikki Huikuri, Olavi Ukkola, Giovanni Targher. Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study). PLOS ONE 2015; 10(11): e0142937 doi: 10.1371/journal.pone.0142937
66
Jelena Stevanović, Jorge Beleza, Pedro Coxito, António Ascensão, José Magalhães. Physical exercise and liver “fitness”: Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease. Molecular Metabolism 2020; 32: 1 doi: 10.1016/j.molmet.2019.11.015
67
María José Morlán-Coarasa, María Teresa Arias-Loste, Víctor Ortiz-García de la Foz, Obdulia Martínez-García, Carmen Alonso-Martín, Javier Crespo, Manuel Romero-Gómez, Emilio Fábrega, Benedicto Crespo-Facorro. Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study. Psychopharmacology 2016; 233(23-24): 3947 doi: 10.1007/s00213-016-4422-7
68
Dan-Qin Sun, Wen-Yue Liu, Sheng-Jie Wu, Gui-Qi Zhu, Martin Braddock, Dong-Chu Zhang, Ke-Qing Shi, Dan Song, Ming-Hua Zheng. Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease. Oncotarget 2016; 7(5): 5728 doi: 10.18632/oncotarget.6799
69
Milena Tauil Auad Noronha Santos, Cristiane Alves Villela-Nogueira, Nathalie Carvalho Leite, Patrícia de Fátima dos Santos Teixeira, Marcus Vinicius Leitão de Souza. Use of transient elastography for hepatic steatosis and fibrosis evaluation in patients with subclinical hypothyroidism. Archives of Endocrinology and Metabolism 2024; 68 doi: 10.20945/2359-4292-2023-0477
70
Jingru Su, Liyuan Zhou, Jia Liu, Ying Wang, Guang Wang. Noninvasive liver fibrosis markers are independently associated with carotid atherosclerosis risk in patients with nonalcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 2024; 59(8): 961 doi: 10.1080/00365521.2024.2364878
71
Kun Lian, Yu‐Nan Feng, Rong Li, Hao‐Lin Liu, Peng Han, Lei Zhou, Cheng‐Xiang Li, Qin Wang. Middle‐ and high‐molecular weight adiponectin levels in relation to nonalcoholic fatty liver disease. Journal of Clinical Laboratory Analysis 2020; 34(4) doi: 10.1002/jcla.23148
72
Sabine Hörist-Kollmann, Jeanette Strametz-Juranek. Female Dietary Patterns and the Pathogenesis of NAFLD. Gender and the Genome 2018; 2(2): 49 doi: 10.1177/2470289718787091
73
L. Farzin, S. Asghari, M. Rafraf, M. Asghari-Jafarabadi, M. Shirmohammadi. No beneficial effects of resveratrol supplementation on atherogenic risk factors in patients with nonalcoholic fatty liver disease. International Journal for Vitamin and Nutrition Research 2020; 90(3-4): 279 doi: 10.1024/0300-9831/a000528
74
Aleksandra Klisic, Nebojsa Kavaric, Ana Ninic. Predictive values of serum uric acid and Alanine-aminotransferase for fatty liver index in Montenegrin population. Journal of Medical Biochemistry 2019; 38(4): 407 doi: 10.2478/jomb-2019-0001
75
Heidi Storgaard, Lise L. Gluud, Cathy Bennett, Magnus F. Grøndahl, Mikkel B. Christensen, Filip K. Knop, Tina Vilsbøll, Noel Christopher Barengo. Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. PLOS ONE 2016; 11(11): e0166125 doi: 10.1371/journal.pone.0166125
76
Rina Wu, Feng Hou, Xiaomin Wang, Yong Zhou, Kai Sun, Youxin Wang, Henghui Liu, Jing Wu, Ruiping Zhao, Jiang Hu. Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification in a Northern Chinese Population: a Cross Sectional Study. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-09851-5
77
Rossella D’Oria, Valentina Annamaria Genchi, Cristina Caccioppoli, Isabella Calderoni, Nicola Marrano, Giuseppina Biondi, Anna Borrelli, Ludovico Di Gioia, Francesco Giorgino, Luigi Laviola. Impact of Dysfunctional Adipose Tissue Depots on the Cardiovascular System. International Journal of Molecular Sciences 2022; 23(22): 14296 doi: 10.3390/ijms232214296
78
Saumya Jayakumar, Stephen A. Harrison, Rohit Loomba. Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease. Current Hepatology Reports 2016; 15(2): 86 doi: 10.1007/s11901-016-0296-8
79
亚楠 王. Predictive Value of APRI and TyG in the Diagnosis of MAFLD and Its Fibrosis. Advances in Clinical Medicine 2023; 13(07): 11455 doi: 10.12677/ACM.2023.1371601
80
AA Pavlova, SO Klyuchnikov, MS Tarasova, VS Feshchenko, AV Zholinsky, SA Parastaev. Metabolic syndrome: risks in youth sports. Medicine of Extreme Situations 2023; (2023(2)) doi: 10.47183/mes.2023.014
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345